Record Details

Bacteriocins: perspective for the development of novel anticancer drugs.

DIR@IMTECH: CSIR-Institute of Microbial Technology

View Archive Info
 
 
Field Value
 
Title Bacteriocins: perspective for the development of novel anticancer drugs.
 
Creator Baindara, Piyush
Korpole, Suresh
Grover, Vishakha
 
Subject QR Microbiology
 
Description Antimicrobial peptides (AMPs) from prokaryotic source also known as bacteriocins are ribosomally synthesized by bacteria belonging to different eubacterial taxonomic branches. Most of these AMPs are low molecular weight cationic membrane active peptides that disrupt membrane by forming pores in target cell membranes resulting in cell death. While these peptides known to exhibit broad-spectrum antimicrobial activity, including antibacterial and antifungal, they displayed minimal cytotoxicity to the host cells. Their antimicrobial efficacy has been demonstrated in vivo using diverse animal infection models. Therefore, we have discussed some of the promising peptides for their ability towards potential therapeutic applications. Further, some of these bacteriocins have also been reported to exhibit significant biological activity against various types of cancer cells in different experimental studies. In fact, differential cytotoxicity towards cancer cells as compared to normal cells by certain bacteriocins directs for a much focused research to utilize these compounds as novel therapeutic agents. In this review, bacteriocins that demonstrated antitumor activity against diverse cancer cell lines have been discussed emphasizing their biochemical features, selectivity against extra targets and molecular mechanisms of action.
 
Publisher Springer Nature
 
Date 2018-12-18
 
Type Article
PeerReviewed
 
Relation https://link.springer.com/article/10.1007%2Fs00253-018-9420-8
http://crdd.osdd.net/open/2140/
 
Identifier Baindara, Piyush and Korpole, Suresh and Grover, Vishakha (2018) Bacteriocins: perspective for the development of novel anticancer drugs. Applied microbiology and biotechnology, 102 (24). pp. 10393-10408. ISSN 1432-0614